Upgrade to SI Premium - Free Trial

Anavex Life Sciences (AVXL) Confirms Information in July 27 Press Release Announcing Positive Results from Phase 2a Alzheimer's Trial for ANAVEX 2-73

July 29, 2016 9:22 AM
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), confirms the information in the July 27, 2016 press release ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments Momentum Movers Short Sales

Next Articles